Kiora Pharmaceuticals, Inc.
KPRXKiora Pharmaceuticals is a clinical-stage specialty biotechnology company focused on developing and commercializing therapies for orphan retinal diseases.
$11.26M+38.0%
Table of contents
Earnings
Next report
Aug 7, 2026 (In 1 week)EPS estimate-$0.47
Competitors
By market cap
By revenue growth
Profile
Kiora Pharmaceuticals is a clinical-stage specialty biotechnology company focused on developing and commercializing therapies for orphan retinal diseases. The company leverages small molecule platforms to restore vision in patients with inherited and age-related degenerative retinal diseases and to treat intraocular inflammatory conditions.
Competitive position
Kiora is a pioneer in the 'photoswitch' small molecule space for vision restoration, holding Orphan Drug Designations from both the FDA and EMA.
GeographiesUnited States, European Union
Customer segmentsSpecialty healthcare providers, Ophthalmologists, Orphan disease patients
Business modelR&D-stage biotechnology, Licensing and royalties
SuppliersContract research organizations, Specialized chemical manufacturers, Clinical trial sites
CustomersPharmaceutical commercialization partners, Specialty pharmacies, Ophthalmic clinics
CountryUnited States of America
Listed2015
Employees12.0
CEOBrian Strem
SectorHealthcare
IndustryBiotechnology
Websitekiorapharma.com
FilingsSEC EDGAR
Questions, answered.
- What is Kiora Pharmaceuticals, Inc.'s market cap?
- Kiora Pharmaceuticals, Inc. (KPRX) has a market capitalization of $11.3M and trades on NASDAQ.
- Who are Kiora Pharmaceuticals, Inc.'s competitors?
- Kiora Pharmaceuticals, Inc.'s key competitors include Kodiak Sciences Inc Common Stock, Aldeyra Therapeutics, Inc., Kalaris Therapeutics, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Kiora Pharmaceuticals, Inc. partner with?
- Kiora Pharmaceuticals, Inc.'s notable partners include Théa Open Innovation, Laboratories Théa.
- What subsidiaries does Kiora Pharmaceuticals, Inc. have?
- Kiora Pharmaceuticals, Inc.'s subsidiaries include Bayon Therapeutics, Inc., Panoptes Pharma GmbH.
- Where is Kiora Pharmaceuticals, Inc. headquartered?
- Kiora Pharmaceuticals, Inc. is headquartered in United States of America and employs approximately 12 people. It has been publicly traded since 2015.